The research line acute renal failure kidney focuses in extracorporeal replacement therapies and acute kidney injury.

Mainly attention has been focused on continuous renal replacement therapy (CRRT), to which absorptive therapies and hepatic replacement therapies have been linked. In relation to CRRT we have recently participated in the REGISFRA multicentric study, whose objective was to draw a map of CRRT in Catalonia. In addition, our attention is focused on projects of therapy optimization concerning type and dosage as well as in biomarkers that can early predict the requirement of CRRT in our patients.

In relation to acute kidney injury (AKI), the projects are based on the early recognition of patients at risk for AKI and on the prophylactic measures necessary to prevent these patients from finally developing an AKI.